Content uploaded by Gokhan Koca
Author content
All content in this area was uploaded by Gokhan Koca on Nov 28, 2015
Content may be subject to copyright.
Copyright © 2015 The Korean Society of Plastic and Reconstructive Surgeons
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
www.e-aps.org
695
Original Article
INTRODUCTION
The introduction of flaps to plastic surgery had a major impact
on wound closure and the reconstruction of normal and func-
tional anatomical features. Local skin flaps provide an excellent
match in terms of color, texture, and thickness. However, it is
The Vasodilator Effect of a Cream Containing 10%
Menthol and 15% Methyl Salicylate on Random-
Pattern Skin Flaps in Rats
Utku Can Dölen1, Nezih Sungur2, Gökhan Koca3, Onur Ertunç4, Ayşe Tülay Bağcı Bosi5,
Uğur Koçer2, Meliha Korkmaz3
1Department of Plastic Surgery, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara; 2Plastic Surgery
Clinic, Ankara Training and Research Hospital, Ankara; 3Department of Nuclear Medicine, Ankara Training and Research Hospital,
Ankara; 4Department of Pathology, Medical School of Gazi University, Ankara; 5Department of Public Health, Medical School of Hacettepe
University, Ankara, Turkey
Background It is still difficult to prevent partial or full-thickness flap necrosis. In this study,
the effects of a cream containing menthol and methyl salicylate on the viability of random-
pattern skin flaps were studied.
Methods Forty female Sprague-Dawley rats were divided into two equal groups. Caudally
based dorsal random-pattern skin flaps were elevated, including the panniculus carnosus. In
the study group, 1.5 mL of a cream containing menthol and methyl salicylate was applied to
the skin of the flap, and saline solution (0.9%) was used in the control group. Upon
completion of the experiment, flap necrosis was analyzed with imaging software and
radionuclide scintigraphy. Histopathological measurements were made of the percentage of
viable flaps, the number of vessels, and the width of the panniculus carnosus muscle.
Results According to the photographic analysis, the mean viable flap surface area in the
study group was larger than that in the control group (P = 0.004). According to the
scintigrams, no change in radioactivity uptake was seen in the study group (P> 0.05).
However, a significant decrease was observed in the control group (P = 0.006). No statistically
significant differences were observed between the groups in terms of the percentage of
viable flaps, the number of vessels, or the width of the panniculus carnosus muscle (P > 0.05).
Conclusions Based on these results, it is certain that the cream did not reduce the viability of
the flaps. Due to its vasodilatory effect, it can be used as a component of the dressing in
reconstructive operations where skin perfusion is compromised.
Keywords Surgical flaps / Menthol / Methyl salicylate / Vasodilator agents / Perfusion
Correspondence: Utku Can Dölen
Department of Plastic Surgery, Dr.
Abdurrahman Yurtaslan Ankara
Oncology Training and Research
Hospital, Demetevler, Ankara 06200,
Turkey
Tel: +90-312-336-0909
Fax: +90-312-595-3656
E-mail: utkuchan@gmail.com
No potential conflict of interest relevant
to this article was reported.
Received: 10 Feb 2015 • Revised: 6 Jun 2015 • Accepted: 17 Aug 2015
pISSN: 2234-6163 • eISSN: 2234-6171 • http://dx.doi.org/10.5999/aps.2015.42.6.695 • Arch Plast Surg 2015;42:695-703
Dölen UC et al. Menthol methyl salicylate rat skin flap
696
not always possible to predict the viability of flaps, especially in
random-pattern skin flaps.
Partial or total flap loss may result in a new tissue defect at the
flap donor area, increasing the total defect area requiring recon-
struction. Such complications may increase the length of the
hospital stay, the cost of the treatment, and most importantly,
may damage the patient’s confidence and trust in his/her doc-
tor. In the literature, numerous surgical and pharmacological
methods of increasing flap viability have been described. Phar-
macological agents such as sympatholytics, vasodilators, calci-
um channel blockers, hemorheologics, prostaglandin inhibitors,
anticoagulants, glucocorticoids, and free radical scavengers have
been applied topically [1-3] and administered enterally or par-
enterally [4,5]. The use of some drugs with proven experimen-
tal efficacy has been restricted by side effects, high cost, and/or
poor availability.
Menthol is a natural and readily available agent used for a vast
range of purposes, including hygiene products, pharmaceuticals,
and as a flavor [6,7]. Menthol has antipruritic, antiseptic, anal-
gesic, anesthetic, and cooling effects when used topically. In ad-
dition, it has antibacterial, antiviral, and antifungal effects [7].
Calcium (Ca2+) channels play a major role in the regulation of
vascular tone. The transient receptor potential (TRP) channel
superfamily has non-voltage-gated cation-permeable channels.
The vanilloid-related (TRPV) and melastatin-related (TRPM)
TRP receptors are two major families that are responsible for
sensing acidity, osmolarity, mechanical forces, and temperature
in non-vascular tissues [8]. TRPM8, known as the menthol or
cold receptor, has been found in arterial smooth muscle. Limit-
ed and contradictory data exist regarding the effect of menthol
on vessels, with disagreement about whether it results in vasodi-
latation [8,9] or vasoconstriction [10-13].
Non-steroid anti-inflammatory drugs (NSAIDs) are the active
ingredients of topical analgesics that are widely used to relieve
muscle and joint pains. NSAIDs inhibit the cyclooxygenase en-
zyme that transforms arachidonic acid into various prostaglan-
dins. A decrease in the amount of prostaglandins, which activate
nociceptors, alleviates the pain. Methyl salicylate (MeSa) is hy-
drolyzed to salicylate, which has anti-inflammatory and analge-
sic effects [14]. In addition, it irreversibly inhibits platelet aggre-
gation [15] and increases local blood flow and the temperature
of the tissue.
We hypothesized that a combination of menthol and MeSa
could affect the viability of skin flaps due to the anti-inflamma-
tory properties of these compounds and their effects on blood
vessels. No similar previous studies were found in a thorough
review of the English-language, French-language, and Turkish-
language literature. In this experimental study, the effects of a
topical cream containing 10% menthol and 15% MeSa (Kamfo-
lin, Münir Şahin, Istanbul, Turkey) on the viability of dorsal ran-
dom-pattern skin flaps in rats were investigated.
METHODS
This research was conducted with the permission of the local
ethical committee and in accordance with international health
and medical research guidelines for animal welfare. The rats
were housed in separate cages, placed in an environmentally
controlled room, and fed with standard rat chow and tap water
ad libitum. Three days before surgery, 200 mg/kg of paracetamol
(Parol, Atabay, Istanbul, Turkey) was added to their water for
analgesia. All surgical procedures and imaging studies were per-
formed under general anesthesia, which was carried out with an
intraperitoneal injection of 75−100 mg/kg of ketamine hydro-
chloride (Ketalar, Eczacıbaşı, Istanbul, Turkey) and 10 mg/kg
of 2% xylazine (Rompun, Bayer, Leverkusen, Germany). The
dorsal hair was removed with an electric shaver and all surgical
procedures were carried out under sterile conditions by a single
surgeon (UCD).
Experimental protocol
Forty adult (three months old) female Sprague-Dawley rats
weighing 179–267 g were divided into two groups of 20 each.
Modified version of the McFarlane was performed. A caudally
based skin flap (10 cm × 3 cm) was marked on the shaved dor-
sum of the rat, starting from the line that connects the iliac spines.
The flap was elevated beneath the panniculus carnosus muscle
(PCM) in both groups, and the deep circumflex iliac artery and
perforator vessels were cauterized in order to ensure a random
pattern of blood circulation. The flaps were sutured back to their
donor site after the scintigraphic measurements were performed
(Fig. 1). A sterile silicone sheet (0.5 mm) was placed on the do-
nor site in order to isolate the flap from the underlying bed.
Study group (n=20)
1.5 mL (0.05 mL/cm2) of a cream containing 10% menthol and
15% MeSa was applied via massage on the skin of the flap im-
mediately after the skin closure and once a day for six days. Be-
fore each application, debris from the previous application was
removed with sterile isotonic saline solution (0.9%).
Control group (n=20)
Sterile isotonic saline solution (0.9%) was applied via massage
on the skin of the flap immediately after the skin closure and
once a day for six days, in order to control for the vasodilatory
effect of the massage [16].
Vol. 42 / No. 6 / November 2015
697
Weight analysis of the rats
All the rats were weighed before and after the experimental pro-
tocol with a digital scale in order to evaluate their physiological
response to the surgery and to the cream.
Clinical and photographic analysis
All flaps were evaluated daily. On the seventh postoperative day,
the rats were anesthetized and standardized photographs of the
flaps were taken with a high-resolution digital camera (Fujifilm
FinePix F80EXR, Fujifilm Holdings Corp., Beijing, China) be-
fore suture removal. These images were then uploaded to a
computer, and the surface areas of the entire flap and the ne-
crotic part of the flap were calculated in mm2 using Adobe Pho-
toshop CS5 software (Adobe Systems Inc., San Jose, CA, USA)
(Fig. 2). The surface area of the viable part of the flap was calcu-
lated by subtracting the surface area of the necrotic part of the
flap from the surface area of the entire flap. Comparisons were
made within and between the two groups.
Radionuclide scintigraphic analysis
On the first day of the experiment, scintigrams of the flaps were
taken before skin closure; on the seventh day, scintigrams were
obtained and the rats were then sacrificed. The rats were inject-
ed with 1 mCi (37 MBq) of technetium-99m pertechnetate
(Tc99m-PO4) in 0.1 mL of isotonic saline solution through the
tail vein. The rats were placed prone under a single-head gamma
camera equipped with a pinhole collimator (Siemens E.Cam,
Siemens Medical Solutions, Hoffman Estates, IL, USA). Images
of both groups were taken five minutes after injection and were
visualized for five minutes in a 256 ×256-pixel matrix. One lead
plate was placed under the flap and two other plates covered the
rest of the rat in order to obtain only the image of the flap. The
lead plates were covered with waterproof paper; separate sets of
waterproof paper were used in each rat in order to protect the
plates from radioactive contamination.
Tc99m-PO4-soaked cotton in a needle cap was placed at the
distal end of the flap in order to visualize the distal border of the
flap on the scintigram. After five seconds, it was removed and
the actual scintigram was obtained.
An experienced nuclear medicine specialist who was blinded
to the groups interpreted the scintigrams. On the computer, a
rectangle was drawn that enclosed the borders of the flap, en-
compassing the total region of interest (ROI). The total ROI
was divided into three equal ROIs: the proximal ROI (from the
pedicle) was referred to as ROI A, the middle third was referred
to as ROI B, and the distal third was referred to as ROI C (Fig.
3). The borders of the hyperemic parts of the flap were drawn
manually, using the free hand method, and the flap area was cal-
culated (Fig. 4). Those values were referred to as the manually
marked count of the viable flap area (MCFA). All results were
compared within each group and between the two groups.
The photographs and the scintigrams were merged digitally
with Adobe Photoshop CS5 software to better visualize the via-
ble part of the flap (Figs. 5, 6).
The dashed line represents the measured surface area.
Fig. 2. Measurement of the necrotic area of the flap
surface
(A) Elevation of a caudally based dorsal skin flap, (B) skin closure and application of 1.5 mL of cream on a rat in the study group.
Fig. 1. A modified McFarlane flap
A B
Dölen UC et al. Menthol methyl salicylate rat skin flap
698
Histopathologic assessment
On the seventh day, the rats were sacrificed with high-dose ket-
amine after scintigraphic imaging. The flaps were divided from
their base between the two iliac spines. The entire flap was fixed
in 10% formaldehyde solution. After routine hospital-specified
histopathological procedures, the paraffin-embedded speci-
mens were sliced longitudinally into 5-μm thick segments along
the long axis of the flap. All specimens were stained with hema-
toxylin and eosin and examined under light microscopy (Shang-
hai Optical Instrument Factory, Shanghai, China) by the same
pathologist who was kept blind to the groups.
The percentages of the viable and necrotic parts of each flap
were measured. The erythrocyte-containing capillary vessels
were then counted in the pedicle region, before the necrotic re-
The measurement of the manually marked count of the viable flap
area is shown by an asymmetric line that encloses the hyperemic
area of the flap. The rectangle represents the entire flap area. A
scintigram was taken (A) before and (B) after the experiment.
Fig. 4. Measurement of the manually marked count of the
viable flap area
A B
An image obtained after digitally combining the photographs and
the scintigrams. In the study group, (A) scintigrams taken before
the experiment showed little perfusion in the flap, while (B) scinti-
grams taken after the experiment showed almost no perfusion in
the flap.
Fig. 5. Combination of a scintigram and a photograph
A B
In the control group, (A) half of the flap was perfused before the
experiment, and (B) perfusion was only found in the pedicle region
after the experiment.
Fig. 6. Combination of a scintigram and a photograph
A B
Measurements of the ROIs on flaps in the (A, B) study and (C, D)
control groups. The flaps were divided into three ROIs, referred to as
ROI A, ROI B, and ROI C. Scintigrams (A, C) before and (B, D) after
the experiment. The white arrow shows the radionuclide-soaked
material that was used to identify the end of the flap.
Fig. 3. Measurements of the regions of interest (ROIs)
A
C
B
D
Vol. 42 / No. 6 / November 2015
699
gion, and at the transition zone between those regions. These
counts were performed at five different areas under high magni-
fication (400 × ) in each region in order to calculate the density
of capillary vessels per 1 mm2. The vessels were counted both at
the level of the papillary dermis and inferior to the PCM, and
the results were compared between the two groups (Fig. 7).
Microscopic images (40× ) of the flaps were photographed.
The thickness of PCM muscle was measured at the pedicle re-
gion, the necrotic region, and at the transition zone between
these regions with the help of Adobe Photoshop CS5. Muscle
thickness was measured in three different places in each region,
and the arithmetic average of these measurements was used as
the muscle thickness value for each region (Fig. 7).
Statistical analysis
Since the scintigraphy results were not normally distributed, a
base-10 logarithmic transformation was applied. The trans-
formed values were used for statistical analysis.
The Mann-Whitney U test was used to compare the necrotic,
viable, and total surface areas of the flaps, as calculated by photo-
graphic analysis. The ROIs and the MCFA were measured using
radionuclide scintigraphy, and the percentage of necrotic areas,
capillary vessel density, and the thickness of the PCM were ana-
lyzed by histopathology and compared between the study group
and the control group. The Wilcoxon signed-rank test was used
to compare the weight of the rats, the ROIs, and the MCFA with-
in the same group. The Kruskal-Wallis test was used to compare
the thickness of the PCM in different regions of the same flap.
Statistical analysis was performed using SPSS ver. 15.0 (SPSS
Inc., Chicago, IL, USA). Data were expressed as the mean±
standard deviation, and the cut-off point for statistical signifi-
cance was 0.05.
RESULTS
Two rats in the control group and one rat in the study group
died of unknown causes before the study was completed. Nei-
ther wounds nor systemic infections were observed in the sur-
viving rats.
Weight analysis of the rats
Before the experimental protocol, the median weight of the
study group was 227 g (range, 204–249 g), and that of the con-
trol group was 211 g (range, 193–233.3 g). On the seventh post-
operative day, the median weight of the study group was 205 g
(range, 183–227 g), and that of the control group was 195.5 g
(range, 182–213.8 g). No statistically significant difference was
observed between the two groups before (P= 0.13) and after
(P= 0.28) the experimental protocol. These figures show that
the rats were distributed randomly. The weight of the rats de-
creased to a statistically significant extent by the end of the ex-
periment in both the study (P<0.001) and control groups
(P = 0.001).
Clinical and photographic analysis
No statistically significant difference between the groups was
found in the total surface areas of the flaps (P= 0.6). This find-
ing indicates that similarly sized flaps were elevated in both
groups. The viable flap area of the study group (median, 15.8
cm2) was larger than that of the control group (median, 8.5
(A) Measurement of capillary vessel density (H&E, ×400). (B) Measurement of the thickness of the panniculus carnosus muscle (PCM) at three
different points in the necrotic region. An asterisk shows the dermal layer, the plus sign indicates the PCM, black arrows show the vessels, and
double arrows indicate the thickness of the PCM (H&E, ×40).
Fig. 7. Histopathology
A B
Dölen UC et al. Menthol methyl salicylate rat skin flap
700
cm2), which was a statistically significant difference (P= 0.004)
(Table 1, Fig. 8).
Radionuclide scintigraphic analysis
No statistical difference was observed in the values of ROI A be-
fore and after the experimental protocol in either the study
group (P= 0.51) or the control group (P= 0.09). A statistically
significant decrease was observed in the values of ROI B and
ROI C, both in the study group (P= 0.04 and P= 0.01, respec-
tively) and in the control group (P = 0.01 and P=0.00, respec-
tively).
A statistically significant decrease was found in the total ROI
of the control group after the experiment (P= 0.006). No statis-
tically significant difference was observed in the values of the to-
tal ROI of the study group (P=0.11). Despite the reduction in
both ROI B and ROI C in the study group, the total ROI did
not change significantly (Table 2).
No statistical differences were observed in all ROI values be-
tween the study and the control group before and after the ex-
perimental protocol. This finding shows that the pattern of
blood perfusion was similar among the flaps.
In the study group, the MCFA did not change after the experi-
mental protocol (P= 0.32). However, it decreased in the control
group (P =0.01) (Table 2).
No statistically significant difference was found in the pre-ex-
perimental scintigraphic values of the study group and the con-
trol group (MCFA, P =0.17). No statistically significant differ-
ence was found in the post-experimental scintigraphic values of
the two groups (MCFA, P= 0.11).
Histopathologic assessment
It was observed under the microscope that 36.18%± 20.79% of
the flaps in the study group and 28.22%± 10.31% of the flaps in
the control group survived. The difference between the two
groups with respect to the percentage of the viable flaps was not
statistically significant (P =0.18).
Capillary vessel density (the number of vessels in 1 mm2) did
not significantly differ between the study group and the control
group in the pedicle region (17 [range, 11–20] vs. 18 [range,
12.3–22], P= 0.94), the transitional region (21 [range, 15–25]
vs. 19.5 [range, 11–27], P = 0.78), and in the pre-necrotic region
(17 [range, 5–21] vs. 18 [range, 12–24.5], P = 0.22). Likewise,
no significant difference was found between the dermal papil-
lary layer and the layer inferior to the PCM.
The thickness of the PCM (μm) did not show a significant dif-
ference between the study and the control groups in the pedicle
region (212 [range, 163.1–235.2] vs. 210.2 [range, 192.4–
248.9], P= 0.60), the middle region (205.9 [range, 181.9–
244.2] vs. 181.1 [range, 156.8–236.9], P = 0.13), or in the ne-
Table 1. Distribution of the mean flap surface areas in the
study and the control group
Surface area of the
flap (cm2)
Study group
(n = 19)
Control group
(n = 18) P-valuea)
Viable 15.8 (10.2–19.4) 8.5 (5.9–12) 0.004b)
Necrotic 14.2 (11.1–19.6) 20.4 (17.8–23.1) 0.01b)
Total 30.1 (29.5–31.9) 29.9 (29.2–30.9) 0.60
A comparison of the control and study groups according to the median viable,
necrotic, and total flap areas. Values are presented as median (interquartile
range).
a)Mann-Whitney U test; b)Statistically significant.
Table 2. In-group comparison between pre- and post-experimental scintigraphic values
Scintigraphic values Study group (n=19) P-value Control group (n=18) P-value
Before After Before After
Region of interest A 3.7 (3.5–3.9) 3.7 (3.3–3.9) 0.51 3.6 (3.4–3.9) 3.5 (3.3–3.8) 0.09
Region of interest B 3.3 (3.2–3.6) 3.2 (2.8–3.4) 0.04a) 3.0 (2.6–3.2) 2.95 (2.6–3.2) 0.01a)
Region of interest C 3.1 (2.9–3.3) 2.7 (2.4–3.1) 0.01a) 3 (2.7–3.3) 2.5 (2.4–2.8) <0.01a)
Region of interest total 3.9 (3.8–4.2) 3.9 (3.5–4.1) 0.11 3.9 (3.7–4.1) 3.7 (3.5–3.9) 0.006a)
Manually marked count of viable flap area 3.9 (3.8–4.2) 3.8 (3.4–4) 0.06 3.8 (3.7–4.1) 3.7 (3.4–3.8) 0.01a)
Values are presented as median (interquartile range). P-value is calculated with Wilcoxon signed-rank test.
a)Statistically significant.
Fig. 8. Mean flap surface areas
35
30
25
20
15
10
5
0
Flap surface area (cm2)
Study group Control group
45% 31%
Necrotic
Viable
Vol. 42 / No. 6 / November 2015
701
crotic region (264.8 [range, 194.4–329.5] vs. 306.1 [range,
213.6–378.9], P = 0.83).
DISCUSSION
Flaps are the most important weapon in the arsenal of plastic
surgeons. Even though their use is as old as the history of hu-
mankind, some aspects of flap viability remain unknown. Sir
Harold Gillies said that “plastic surgery is a constant battle be-
tween blood supply and beauty,” and in this battle, the mission
of plastic surgeons is to elevate a flap without partial or total flap
loss. Especially in random-pattern flaps, blood perfusion is the
major issue that limits the size of the flap. Surgical delay is an ef-
ficient method, but requires multiple operations that not all pa-
tients can tolerate or accept. In contrast, pharmacologic agents
do not require additional surgery, but are often of limited utility
due to their high costs and restricted availability. Among these
agents, topical drugs are the most advantageous because they
can reach a therapeutic dose without causing any systemic side
effects. In addition, patients can easily use these drugs immedi-
ately after surgery, even if they are experiencing nausea, and they
can apply them by themselves at home without medical super-
vision. Topical agents require a skin permeation enhancer, such
as terpenes, in order to be absorbed through the cutaneous lay-
ers. Due to its lipophilic structure, menthol can easily pass the
stratum corneum and its chiral center enhances the absorption
of other molecules [17]. It has already been shown that menthol
facilitates and accelerates the absorption of MeSa [18].
A sterile silicone sheet was used to prevent the skin flap from
surviving as a graft [19,20]. We observed loose capsule forma-
tion and a small seroma around the sheet at the end of the ex-
periment. In the literature, the necrotic part of random-pattern
dorsal skin flaps has been reported to vary widely, from 22% to
50% [21]. In our study, the percentage of necrotic areas in the
flaps in the control group was found to be 69% in the photo-
graphic analysis and 72% in the histopathological analysis. We
interpreted this high percentage of necrosis as the result of the
silicone sheet, which prevented the flaps from undergoing plas-
matic imbibition and revascularization from the underlying bed.
We concluded that the cream did not cause any pain or irrita-
tion, because no significant differences were observed between
the two groups in terms of post-experimental weight and in the
consumption of water and food.
Johnson et al. [8] showed that rat blood vessels contain TRPM8
channels, which cause vasodilatation or vasoconstriction depen-
ding on the existing vascular tone. TRPM8 channels are also pre-
sent in human blood vessels and regulate vasomotor tone. It has
already been reported that Ca2+ channel blockers increase flap
survival [15,22] and if menthol uses the same pathway, it can be
hypothesized to increase flap viability [23].
Namer et al. [9] tested the effect of 40% menthol solution on
healthy humans. They used laser Doppler to show that menthol
increased the superficial blood flow in the area of the forearm
where menthol was applied. Olive et al. [10] compared the ef-
fects of a cream containing 3.5% menthol and ice on the brachial
artery of 12 healthy humans using ultrasound. Contrary to Na-
mer et al., they found that menthol decreased blood flow. Topp
et al. [24] also performed a similar study and found that both
3.5% menthol gel and 0.5 kg ice decreased the blood flow of the
radial artery without changing the diameter of the artery or the
pulse of the subjects. In another study, they investigated the ef-
fect of 3.5% menthol gel and a 10% menthol wipe on the thigh
after three isokinetic maximum voluntary muscular contrac-
tions of the quadriceps and hamstrings. They found that the ap-
plication of the gel decreased the blood flow in the popliteal ar-
tery, which had been increased after isokinetic exercises [11]. It
was hypothesized that topical menthol causes vasoconstriction
by inhibiting the nitric oxide system [13], and that its local cool-
ing property acts through a mechanism similar to that of cold
temperature sensations, which are perceived through α2c adren-
ergic receptors [12].
In addition to adrenergic vasoconstriction, platelet aggregation
in the microvascular system plays a major role in ischemic ne-
crosis of skin flaps. After trauma or surgery, thromboxane A2
(TXA2) released from the platelets causes vasoconstriction and
platelet aggregation. In normal conditions, prostacyclin released
from the vascular endothelium blocks the effect of TXA2. How-
ever, after vascular damage, the amount of TXA2 rises and that
of prostacyclin decreases, and the perfusion of the tissue is
therefore decreased. Salicylates, TXA2 inhibitors, and selective
TXA2 antagonists increase the viability of random-pattern skin
flaps [15,25]. MeSa, like all other salicylates, is a strong inhibitor
of prostaglandin synthase and platelet aggregation. We hypothe-
sized that MeSa would potentially increase flap survival through
this mechanism.
As described above, conflicting data exist regarding the effect
of menthol on vascular tone and blood flow. However, the stud-
ies showing a vasoconstrictive effect of menthol only investigat-
ed the blood flow of the major arteries and did not evaluate cu-
taneous blood flow. In our experiment, we indirectly observed
the blood circulation of the skin while investigating flap survival.
Photographic analysis showed that the cream increased flap via-
bility, although the number of the vessels did not change after
the experiment. The finding that the total ROI and MCFA of
the study group did not change, while the total ROI of the con-
trol group decreased after the experiment, may be attributed to
Dölen UC et al. Menthol methyl salicylate rat skin flap
702
the vasodilatory effect of the cream. This effect could possibly
be used in flap surgeries or replantations in order to increase the
perfusion of the flap. However, it was not found to increase the
overall viability of the flaps.
A limitation of our study was the absence of a control group
using a control cream instead of saline. Moreover, laser Doppler
or angiography could have provided more reliable results re-
garding the vasodilatory effect of the cream than scintigraphy,
which provides functional imaging of living cells. Immunologi-
cal stains could have shown neoangiogenesis more clearly.
Based on these results, it is certain that the cream containing
10% menthol and 15% methyl salicylate did not reduce the via-
bility of the flaps. Its vasodilatory effect means that it can be in-
corporated as part of the dressing in reconstructive operations
where skin perfusion is compromised. Nevertheless, further ex-
periments are necessary to determine the optimal concentra-
tions of menthol and MeSa (alone or in combination) for im-
proving flap viability.
REFERENCES
1. Rinker B, Fink BF, Barry NG, et al. The effect of calcium
channel blockers on smoking-induced skin flap necrosis.
Plast Reconstr Surg 2010;125:866-71.
2. Chen W, Yang D, Wang P, et al. Microencapsulated myo-
blasts transduced by the vascular endothelial growth factor
(VEGF) gene for the ischemic skin flap. Aesthetic Plast Surg
2011;35:326-32.
3. Miyawaki T, Jackson IT, Bier UC, et al. The effect of capsa-
icin ointment on skin for the survival of a cutaneous flap.
Eur J Plast Surg 2001;24:28-30.
4. Pal S, Khazanchi RK, Moudgil K. An experimental study on
the effect of nifedipine on ischaemic skin flap survival in
rats. Br J Plast Surg 1991;44:299-301.
5. Stadelmann WK, Hess DB, Robson MC, et al. Aprotinin in
ischemia-reperfusion injury: flap survival and neutrophil re-
sponse in a rat skin flap model. Microsurgery 1998;18:354-
61.
6. Patel T, Ishiuji Y, Yosipovitch G. Menthol: a refreshing look
at this ancient compound. J Am Acad Dermatol 2007;57:
873-8.
7. Kamatou GP, Vermaak I, Viljoen AM, et al. Menthol: a sim-
ple monoterpene with remarkable biological properties.
Phytochemistry 2013;96:15-25.
8. Johnson CD, Melanaphy D, Purse A, et al. Transient recep-
tor potential melastatin 8 channel involvement in the regula-
tion of vascular tone. Am J Physiol Heart Circ Physiol
2009;296:H1868-77.
9. Namer B, Seifert F, Handwerker HO, et al. TRPA1 and
TRPM8 activation in humans: effects of cinnamaldehyde
and menthol. Neuroreport 2005;16:955-9.
10. Olive JL, Hollis B, Mattson E, et al. Vascular conductance is
reduced after menthol or cold application. Clin J Sport Med
2010;20:372-6.
11. Topp R, Winchester LJ, Schilero J, et al. Effect of topical
menthol on ipsilateral and contralateral superficial blood
flow following a bout of maximum voluntary muscle con-
traction. Int J Sports Phys Ther 2011;6:83-91.
12. Chotani MA, Flavahan S, Mitra S, et al. Silent alpha(2C)-
adrenergic receptors enable cold-induced vasoconstriction
in cutaneous arteries. Am J Physiol Heart Circ Physiol
2000;278:H1075-83.
13. Green DJ, O’Driscoll G, Blanksby BA, et al. Control of skel-
etal muscle blood flow during dynamic exercise: contribu-
tion of endothelium-derived nitric oxide. Sports Med
1996;21:119-46.
14. Ohta T, Imagawa T, Ito S. Involvement of transient receptor
potential vanilloid subtype 1 in analgesic action of methyl-
salicylate. Mol Pharmacol 2009;75:307-17.
15. Davis RE, Wachholz JH, Jassir D, et al. Comparison of topi-
cal anti-ischemic agents in the salvage of failing random-pat-
tern skin flaps in rats. Arch Facial Plast Surg 1999;1:27-32.
16. Hong CZ, Shellock FG. Effects of a topically applied coun-
terirritant (Eucalyptamint) on cutaneous blood flow and on
skin and muscle temperatures: a placebo-controlled study.
Am J Phys Med Rehabil 1991;70:29-33.
17. Kunta JR, Goskonda VR, Brotherton HO, et al. Effect of
menthol and related terpenes on the percutaneous absorp-
tion of propranolol across excised hairless mouse skin. J
Pharm Sci 1997;86:1369-73.
18. Martin D, Valdez J, Boren J, et al. Dermal absorption of cam-
phor, menthol, and methyl salicylate in humans. J Clin Phar-
macol 2004;44:1151-7.
19. Hammond DC, Brooksher RD, Mann RJ, et al. The dorsal
skin-flap model in the rat: factors influencing survival. Plast
Reconstr Surg 1993;91:316-21.
20. Jones M, Zhang F, Blain B, et al. Influence of recipient-bed
isolation on survival rates of skin-flap transfer in rats. J Re-
constr Microsurg 2001;17:653-8.
21. Cheon YW, Tark KC, Kim YW. Better survival of random
pattern skin flaps through the use of epigallocatechin gallate.
Dermatol Surg 2012;38:1835-42.
22. Komorowska-Timek E, Chen SG, Zhang F, et al. Prolonged
perivascular use of verapamil or lidocaine decreases skin flap
necrosis. Ann Plast Surg 1999;43:283-8.
23. Cheang WS, Lam MY, Wong WT, et al. Menthol relaxes rat
Vol. 42 / No. 6 / November 2015
703
aortae, mesenteric and coronary arteries by inhibiting calci-
um influx. Eur J Pharmacol 2013;702:79-84.
24. Topp R, Ledford ER, Jacks DE. Topical menthol, ice, pe-
ripheral blood flow, and perceived discomfort. J Athl Train
2013;48:220-5.
25. Ghavami A, Nutt MP, Hardy SP. Heat shock protein and
high-dose aspirin: effects on random skin flap survival in a
rat model. Ann Plast Surg 2002;48:60-7.